Biotech stocks have staged an impressive rally over the past six months, with the XBI index – key benchmark for small and mid-cap biotech names – posting one of its strongest stretches on record.Mizuho’s senior healthcare analyst Jared Holz believes this momentum is more than a short-term bounce.Speaking with CNBC,…
Wedbush Securities’ senior analyst, Dan Ives, has names top five tech stocks to own into 2026.Notably, Nvidia – the…
Meta Platforms has agreed to acquire Manus, a Singapore-based developer of general-purpose artificial intelligence agents, marking another major step…
Global markets opened Tuesday digesting a mix of defense contracts, economic data from South Korea, volatile commodity moves, and…
India’s intake of Russian crude is set to mark its weakest month in three years, reflecting how tighter US…
Latin America is heading toward a pivotal year in 2026 as new US tariffs and rising oil output reshape…
China’s electric vehicle (EV) boom is losing momentum in 2025, with sales declining across major players and analysts warning…